General Information of Drug (ID:
DR1841) |
Drug Name |
E-6005
|
Synonyms |
Lotamilast; Lotamilast (USAN/INN); E-6005; Lotamilast [USAN]; RVT-501; SB16962; SCHEMBL369445; TO043KKB9C; ZINC113676839; 947620-48-6; BCP25249; CHEMBL3989967; CS-7517; DB12776; E6005; EX-A1382; MFCD28502071; Methyl 4-((3-(6,7-dimethoxy-2-(methylamino)quinazolin-4-yl)phenyl)carbamoyl)benzoate; Methyl 4-({3-[6,7-dimethoxy-2-(methylamino)quinazolin-4-yl]phenyl}carbamoyl)benzoate; UNII-TO043KKB9C; methyl 4-[[3-[6,7-dimethoxy-2-(methylamino)quinazolin-4-yl]phenyl]carbamoyl]benzoate
|
Indication |
Atopic dermatitis
[ICD11: EA80]
|
Phase 2
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
472.5 |
Topological Polar Surface Area |
112 |
Heavy Atom Count |
35 |
Rotatable Bond Count |
8 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
8 |
Cross-matching ID |
- PubChem CID
- 24864553
- CAS Number
-
- TTD Drug ID
- D0TT4H
- Formula
- C26H24N4O5
- Canonical SMILES
- CNC1=NC2=CC(=C(C=C2C(=N1)C3=CC(=CC=C3)NC(=O)C4=CC=C(C=C4)C(=O)OC)OC)OC
- InChI
- 1S/C26H24N4O5/c1-27-26-29-20-14-22(34-3)21(33-2)13-19(20)23(30-26)17-6-5-7-18(12-17)28-24(31)15-8-10-16(11-9-15)25(32)35-4/h5-14H,1-4H3,(H,28,31)(H,27,29,30)
- InChIKey
- BBTFKAOFCSOZMB-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.